Banerjee Dipanjan, Vikram Naval, Mishra Puneet, Bhatt Rajesh, Prakash Surya, Misra Anoop
Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California 94305, USA.
Metab Syndr Relat Disord. 2009 Jun;7(3):215-9. doi: 10.1089/met.2008.0075.
High rates of insulin resistance (IR), which contribute to a high prevalence of cardiovascular disease (CVD), have been noted in Asian Indians. Rapid, effective measures of IR could identify individuals at risk for CVD in this population. A [(13)C]glucose breath test has been shown to correlate significantly with invasive measures of IR in a Caucasian cohort. We hypothesized that the breath test would correlate significantly with surrogate measures of IR in Asian Indians.
A total of 49 urban and 49 rural Asian Indian subjects underwent the (13)C breath test and 2-hour oral glucose tolerance testing. Correlations were performed between the breath test results and surrogate measures of IR including the homeostasis model of insulin resistance (HOMA). These two indices were also correlated with body mass index (BMI).
In the overall cohort, the breath test correlated significantly with HOMA (r = -0.40; P < 0.0001), waist circumference (WC) (r = -0.70; P < 0.0001), and BMI (r = -0.59; P < 0.0001). The breath test correlated significantly with BMI in the urban and rural cohorts (r = -0.65; P < 0.0001 and r = -0.36; P = 0.01) and with HOMA (r = -0.55; P = 0.0001) in the urban cohort. There was no significant correlation between the breath test and HOMA (r = -0.07; P = 0.61) in the rural cohort. When corrected for WC and BMI, the correlation between the breath test and HOMA in the urban cohort was no longer significant (r = -0.08; P = 0.57).
The (13)C breath test correlated significantly with HOMA values in urban but not in more insulin-sensitive rural subjects and yielded no incremental information over BMI. Further refinement of the [(13)C]glucose breath test is necessary prior to its use as a screening test for IR in Asian Indians.
亚洲印度人胰岛素抵抗(IR)发生率较高,这导致心血管疾病(CVD)患病率较高。快速、有效的IR检测方法可识别该人群中CVD风险个体。在白种人队列中,[13C]葡萄糖呼气试验已被证明与IR的侵入性检测方法显著相关。我们推测该呼气试验与亚洲印度人IR的替代检测方法显著相关。
共49名城市和49名农村亚洲印度受试者接受了13C呼气试验和2小时口服葡萄糖耐量试验。对呼气试验结果与IR替代检测方法(包括胰岛素抵抗稳态模型(HOMA))进行相关性分析。这两个指标还与体重指数(BMI)进行相关性分析。
在整个队列中,呼气试验与HOMA(r = -0.40;P < 0.0001)、腰围(WC)(r = -0.70;P < 0.0001)和BMI(r = -0.59;P < 0.0001)显著相关。呼气试验在城市和农村队列中与BMI显著相关(r = -0.65;P < 0.0001和r = -0.36;P = 0.01),在城市队列中与HOMA(r = -0.55;P = 0.0001)显著相关。在农村队列中,呼气试验与HOMA无显著相关性(r = -0.07;P = 0.61)。校正WC和BMI后,城市队列中呼气试验与HOMA的相关性不再显著(r = -0.08;P = 0.57)。
13C呼气试验在城市受试者中与HOMA值显著相关,但在胰岛素敏感性较高的农村受试者中并非如此,且相对于BMI并未提供更多增量信息。在将[13C]葡萄糖呼气试验用作亚洲印度人IR筛查试验之前,有必要对其进行进一步优化。